Bard Financial Services Inc. Boosts Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Bard Financial Services Inc. raised its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 107.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,750 shares of the company’s stock after purchasing an additional 13,850 shares during the period. Bard Financial Services Inc.’s holdings in Bath & Body Works were worth $1,037,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of the company. True Wealth Design LLC raised its holdings in Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after acquiring an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt raised its stake in shares of Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after purchasing an additional 900 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in Bath & Body Works during the 3rd quarter worth about $39,000. TD Private Client Wealth LLC grew its holdings in Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares in the last quarter. Finally, Meeder Asset Management Inc. lifted its holdings in shares of Bath & Body Works by 480.3% in the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock worth $55,000 after buying an additional 1,436 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Stock Down 2.6 %

BBWI traded down $0.99 during trading on Monday, reaching $36.71. The company had a trading volume of 1,907,606 shares, compared to its average volume of 2,673,765. The business has a 50 day simple moving average of $34.96 and a 200-day simple moving average of $33.84. The stock has a market cap of $7.95 billion, a P/E ratio of 8.95, a PEG ratio of 1.43 and a beta of 1.82. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.03. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.48 earnings per share. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.18%. Bath & Body Works’s dividend payout ratio is presently 19.51%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on BBWI shares. Wells Fargo & Company lifted their price objective on Bath & Body Works from $38.00 to $42.00 and gave the company an “equal weight” rating in a research note on Thursday, December 12th. Piper Sandler upped their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday. JPMorgan Chase & Co. lifted their target price on shares of Bath & Body Works from $35.00 to $39.00 and gave the company a “neutral” rating in a research report on Tuesday, November 26th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Telsey Advisory Group reaffirmed an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Bath & Body Works currently has a consensus rating of “Moderate Buy” and an average target price of $42.69.

Insider Activity at Bath & Body Works

In other news, CEO Gina Boswell bought 6,000 shares of Bath & Body Works stock in a transaction on Wednesday, October 9th. The stock was acquired at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.